DigiStorm 2018 – 3
Tuesday, June 2, 2026
22.8
C
Bengaluru
Hot topics
Interview with Salil Kallianpur
MedicinMan announces workshops on Digital Marketing in Pharma and Sales Force Excellence.
Novo Nordisk to Acquire Akero Therapeutics for $4.7 Billion
Novo Nordisk has announced plans to acquire Akero Therapeutics...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Why Most AI Healthcare Tools Stall at the Pilot Stage
Artificial intelligence (AI) in healthcare consistently demonstrates remarkable technical...
Role of AI Across Pharma Industry
Introduction
Artificial intelligence (AI) is increasingly pivotal in driving innovation...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Hot topics
Is Your Field Force Optimised to Make the Most of Market Growth in Metros?
Summary of Performance of Top 30 Metros in IPM...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
India’s Medical Devices Market: Strategic Implications and Key Investors
KKR's Investments in India's Medical Devices Market: Strategic Implications...
First Approach in Pharma
Independence Day Special issue with Vivek Hattangadi tracing the India pharma brand story from before Independence till today.
Indian Pharma’s November 2025: How GLP-1s Rewired the Market
Indian pharma wrapped up November 2025 with serious velocity....
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Character: The Ultimate Differentiator in Healthcare and Pharma
My friend Salil Kallianpur, in his Substack post "The...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma: The Marketing – Field Disconnect and Its Remedy
The Anomaly
Unless you learn to accept that chaos is...
The Tragic Genius of Yellapragada Subbarow
Every day, doctors worldwide prescribe methotrexate, doxycycline, and folic...
Private Equity Funds in Indian Healthcare: Who Wins? Who Loses?
The Two Headlines That Should Not Coexist
Two recent news...
Newsletter
Get important news delivered directly to your inbox and stay connected!